Preparation and application of fluorescence donor capable of controllably releasing hydrogen sulfide and carbon monoxide
By synthesizing a dual-gas fluorescent donor that controllable release of hydrogen sulfide and carbon monoxide, the existing single-gas donors are difficult to meet the synergistic effect of H2S and CO, and achieve non-destructive release and real-time monitoring in the biological system , provides a powerful molecular tool.
Patent Information
- Application Number
- CN202411175294.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-12-03
AI Technical Summary
Existing monogas donors are difficult to meet the need for synergistic interaction between H2S and CO in research and treatment, and spontaneous donors lack control, and common analytical methods can destroy biological samples.
Using a dual-gas fluorescent donor that can control the release of hydrogen sulfide and carbon monoxide, the HSCO donor with fluorescence signal can be synthesized by reacting the natural product flavonol with sulfophosgene and phenylgrignard reagent, which can be controlled within the biological system. Both gases are released and their release process is monitored by fluorescent signals.
It realizes the non-destructive controllable release of H2S and CO in a biological system and is monitored in real time through fluorescence signals, providing a powerful molecular tool that simplifies the research and detection process.
Smart Images

Figure CN119060007A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biological detection, and in particular relates to the preparation and application of a fluorescent donor capable of controllably releasing hydrogen sulfide and carbon monoxide. Background Art
[0002] Hydrogen sulfide (H 2 S) and carbon monoxide (CO) are important gaseous signal molecules for gas therapy. These two gaseous signal molecules have important physiological effects in the human body and are closely related to many diseases. They are synthesized by enzymes in mammalian cells and are endogenous gaseous signal molecules with unique signal responses. They are widely involved in the regulation of various physiological and pathological activities in organisms.
[0003] Endogenous H 2 In the cardiovascular system, S has multiple biological effects, such as relaxing vascular smooth muscle, lowering blood pressure, promoting apoptosis of vascular smooth muscle cells, and inhibiting proliferation of vascular smooth muscle cells (VSMCs). 2 S can also inhibit the proliferation of pulmonary artery smooth muscle cells, participate in maintaining the normal structure of pulmonary blood vessels, and play an important regulatory role in the structure and function of pulmonary circulation; it increases the level of antioxidant glutathione, inhibits and clears various oxidative substances in the nervous system, etc., and has a wide range of physiological effects.
[0004] In the cardiovascular system, CO can cause smooth muscle relaxation in the carotid, femoral and coronary arteries, and can also regulate the caliber of resistance vessels. In addition, CO can strengthen the decompression reflex, reduce blood pressure and slow heart rate in the regulation of central cardiovascular activity; CO is a recognized nerve messenger in many physiological and pathological processes of the central nervous system. Its source is not limited to the blood circulation. The heme subunits produced by peripheral nerve tissue can also reach and pass through the blood-brain barrier into the brain, and produce CO under the action of local HO. The neuromessenger effect of CO not only involves mechanisms including learning and memory processes, spinal nerve pain transmission, the development and function of olfactory receptor nerves, the regulation of carotid chemosensory activity and the inhibition of autonomic nerve pressor regulation, but also involves processes such as sphincter relaxation and hormone release.
[0005] Due to H 2 Both S and CO have cardiovascular effects, so studying the synergistic effects of the two gases in diseases is of great significance for the occurrence, prevention, and treatment of diseases. Gaseous signal molecules cannot be used directly in biological research or even disease treatment. 2 The gaseous therapeutic effects of S and CO in the human body require gas molecule donors as a research basis to release the relevant gases in situ in the biological system. 2The gaseous therapeutic effects of S and CO in the human body require gas molecule donors as a research basis. The H2S donors and CO donors reported so far, such as hydrogen sulfide donors GYY 4137 and ADT-OH; carbon monoxide donors CORMs, etc., are all single gas molecule donors. In actual biological processes, multiple gases often act together, so a single donor is difficult to meet the needs of research and treatment. At present, most of the donors on the market are spontaneous donors and lack effective control. In the research field, some donors that can control the release of gas signal molecules need to use other analytical methods to analyze the gas in practical applications, such as ultraviolet method, ESR method, etc. These analytical methods will cause damage to biological samples.
[0006] In view of the current technical problems, it is urgent to develop a new type of dual gas molecular donor that can release H simultaneously or separately in a controllable manner. 2 S and CO, and can effectively detect the generated gas signals during actual use without causing damage to biological samples. Summary of the invention
[0007] The present invention aims to provide a dual gas donor that can controllably release hydrogen sulfide and carbon monoxide with a simple preparation method. The donor can controllably release the two gases in a biological system and give a fluorescent signal for real-time monitoring without destroying the biological sample, and can become a powerful molecular tool. The purpose of the present invention is achieved by the following technical solutions:
[0008] A method for preparing a fluorescent donor capable of controllably releasing hydrogen sulfide and carbon monoxide comprises the following steps:
[0009] S1. Dissolving the natural product flavonol (COD) in 15 mL of dry tetrahydrofuran to obtain a tetrahydrofuran mixed solution 1 containing COD;
[0010] S2. The mixed solution 1 described in step S1 was vigorously stirred at 0°C, and 15 mL of a dichloromethane mixed solution containing thiophosgene was slowly added, and the mixture was stirred and reacted for 1 h in an ice bath; after the temperature of the mixed solution returned to room temperature, the mixture was stirred and reacted for 2 h to obtain a mixed solution 2;
[0011] S3. The mixed solution 2 described in step S2 is placed back in an ice bath at 0°C, a phenyl Grignard reagent is added to react, and after the reaction solution temperature gradually returns to room temperature, the end point of the reaction is monitored by TLC;
[0012] S4. After the reaction is completed in step S3, an excess of saturated ammonium chloride solution is added to quench the Grignard reagent, and the reaction solution is extracted three times with dichloromethane, and the organic phases are combined and dried to obtain a solid mixture;
[0013] S5. Separate and purify the solid mixture obtained in step S4 by column chromatography to finally obtain a yellow fluorescent donor.
[0014] Furthermore, the amount of the natural product flavonol (COD) added in step S1 is 300 mg.
[0015] Furthermore, the amount of thiophosgene added to the dichloromethane mixed solution containing thiophosgene in step S2 is 180 mg.
[0016] Furthermore, the phenyl Grignard reagent described in step S3 is one of 3-methoxyphenylmagnesium bromide, 3,4-(methylenedioxy)phenylmagnesium bromide, and 4-fluorophenylmagnesium bromide.
[0017] Furthermore, the amount of the phenyl Grignard reagent added in step S3 is 3 to 5 times equivalent.
[0018] Furthermore, the method of using TLC to monitor the end point of the reaction described in step S3 is to take an appropriate amount of reaction solution, add water to quench the reaction, take the mixed solution and spot it on the TLC plate, blow dry the solvent with a hair dryer, use a mixed solution of dichloromethane and methanol as the developing agent, and develop it with a ratio of dichloromethane: methanol of 20:1. It is observed that the COD point disappears and the new points that appear in the reaction no longer increase.
[0019] Furthermore, the column chromatography method described in step S4 is used for separation and purification under the conditions of using 400 mesh silica gel, the separation phase is a mixture of dichloromethane and methanol, dichloromethane: methanol = 30:1, and the column is pressurized.
[0020] Furthermore, the donor can controllably release two gas signal molecules and give fluorescence signal changes, which can be used to monitor gas release in real time: in the presence of cysteine, hydrogen sulfide is released and red enhanced fluorescence is produced; then, under blue light irradiation, carbon monoxide is released and the red fluorescence signal gradually weakens.
[0021] Another object of the present invention is to provide a fluorescent donor capable of controllably releasing hydrogen sulfide and carbon monoxide for use in biological sample detection.
[0022] Combining all the above technical solutions, the advantages and positive effects of the present invention are as follows:
[0023] (1) The present application uses a one-pot method to synthesize a fluorescent donor that can controllably release hydrogen sulfide and carbon monoxide. The reaction is simple and economical, which is conducive to large-scale promotion and application.
[0024] (2) The synthesized compound HSCO, as a dual gas molecular donor of hydrogen sulfide and carbon monoxide, has no fluorescence signal itself. After adding cysteine, it can release H 2S and generate compound COD, which can generate a product with a fluorescent signal in the solution. Therefore, by detecting the increase in the fluorescence signal intensity of the compound COD in the solution, H 2 The compound COD, as a gas molecule donor of carbon monoxide, has a fluorescent signal itself and can release CO after being irradiated with light of a certain wavelength. Therefore, the amount of CO generated can be determined by detecting the weakening of the fluorescence signal intensity of the compound COD in the solution.
[0025] (3) Since the dual gas molecule donor HSCO first releases hydrogen sulfide in the presence of cysteine in vivo, COD is generated at the same time, and then carbon monoxide is released under the irradiation of light with a wavelength of 410nm. In the presence of cysteine and light, H 2 S and CO. By using H 2 The reaction products were measured by S fluorescent probe and CO fluorescent probe, which proved that the donor HSCO released H 2 S and CO, with the existing H 2 Compared with S donors and CO donors, the dual gas molecule donor HSCO can release H2S and CO simultaneously from one molecular structure, and the fluorescence signal intensity of COD can be detected to determine the H 2 The release process of S and CO realizes the visible and controllable release of the dual-gas molecular donor. Therefore, the donor can controllably release two gases in the biological system and give a fluorescent signal for real-time monitoring without destroying the biological sample, which can become a powerful molecular tool. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 The synthetic route of the method of the present invention is:
[0027] Figure 2 The hydrogen spectrum of the HSCO donor prepared by the method of the present invention;
[0028] Figure 3 The carbon spectrum of the HSCO donor prepared by the method of the present invention;
[0029] Figure 4 The ultra-high resolution mass spectrum of the HSCO donor prepared by the method of the present invention;
[0030] Figure 5 Schematic diagram of the detection principle of the HSCO donor prepared by the method of the present invention.
[0031] Figure 6 This is a confocal fluorescence image of the HSCO donor prepared by the method of the present invention in biological sample detection. DETAILED DESCRIPTION
[0032] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and understandable, the specific implementation methods of the present invention are described in detail below in conjunction with the accompanying drawings. In the following description, many specific details are set forth to facilitate a full understanding of the present invention.
[0033] Example 1
[0034] Dissolve 300 mg of compound COD in 15 mL of dry tetrahydrofuran, stir vigorously in an ice bath at 0°C, and slowly add 15 mL of dichloromethane solution containing 180 mg of thiophosgene. Stir the reaction in an ice bath for 1 hour. After the reaction gradually returns to room temperature, continue stirring the reaction for 2 hours. Then put the reaction solution back in an ice bath (0°C), slowly add 3 times the equivalent of phenylmagnesium bromide, and after the reaction gradually returns to room temperature, TLC monitors the end of the reaction. Then add excess saturated ammonium chloride solution to quench the Grignard reagent, extract the reaction solution three times with dichloromethane, take the organic phase and combine it, and spin dry. Separate by column chromatography, dichloromethane: methanol 30:1.
[0035] Example 2
[0036] Dissolve 500 mg of compound COD in 50 mL of dry tetrahydrofuran, stir vigorously in an ice bath at 0°C, and slowly add 15 mL of tetrahydrofuran solution containing 250 mg of thiophosgene. Remove the reaction solution from the ice bath and continue to stir and react for 1 hour. Then put the reaction solution back in the ice bath (0°C), slowly add 5 times the equivalent of phenylmagnesium bromide, and after the reaction substrate is added, heat the reaction solution to 50°C, react for one hour, add excess saturated ammonium chloride solution to quench the Grignard reagent, extract the reaction solution three times with dichloromethane, take the organic phases and combine them, and spin dry. Separate by column chromatography, dichloromethane: methanol 30:1
[0037] Example 3
[0038] Dissolve 300 mg of compound COD in 15 mL of dry dichloromethane, stir vigorously in an ice bath at 0°C, and slowly add 15 mL of dichloromethane solution containing 180 mg of thiophosgene. Stir the reaction in an ice bath for 1 hour. After the reaction gradually returns to room temperature, continue stirring the reaction for 2 hours. Then put the reaction solution back in an ice bath (0°C), slowly add 3 times the equivalent of 3-methoxyphenylmagnesium bromide, and after the reaction gradually returns to room temperature, TLC monitors the end of the reaction. Then add excess saturated ammonium chloride solution to quench the Grignard reagent, extract the reaction solution three times with dichloromethane, take the organic phase and combine it, and spin dry. Separate by column chromatography, dichloromethane: methanol 25:1.
[0039] Example 4
[0040] HSCO was co-cultured with normal H2C9 cardiomyocytes, H2C9 cardiomyocytes treated with maleimide (NEM), and H2C9 cardiomyocytes treated with maleimide and cysteine (CYS) for 15 minutes, and then imaged using a laser confocal microscope. Normal cells have a certain amount of red fluorescence emitted by HSCO, the NEM-treated group has almost no fluorescence, and the group with CYS has the strongest fluorescence. Explanation: Normal cells contain a certain amount of CYS, and NEM is a substance that removes intracellular thiols. Therefore, after NEM-treated cells are added with CYS, the red fluorescence produced by HSCO in the cells must be stimulated by CYS.
[0041] After HSCO was co-cultured with CYS-treated H2C9 cardiomyocytes for 15 minutes, laser confocal imaging showed strong red fluorescence, which was then irradiated with light for 15 seconds. After 35 seconds, the fluorescence gradually weakened, indicating that after HSCOD was treated with cysteinyl, the red fluorescence gradually weakened when irradiated with light.
[0042] By co-culturing cells with commercial hydrogen sulfide probes, HSCO, and the like, it can be observed that as the red fluorescence produced by HSCO becomes stronger, the blue fluorescence of the hydrogen sulfide probe also becomes stronger. This indicates that the release of hydrogen sulfide by HSCO is accompanied by the enhancement of red fluorescence, and the release of hydrogen sulfide can be monitored in real time in the cell system.
[0043] Similarly, using a commercial carbon monoxide probe and HSCO co-culture, a certain amount of red fluorescence was observed in normal cells. After illumination, the red fluorescence gradually weakened, and the green fluorescence of the carbon monoxide probe gradually increased. This shows that the signal of weakened red fluorescence can represent the release of carbon monoxide. The results are as follows Figure 6 shown.
[0044] Although the present invention has been disclosed as above with preferred embodiments, it is not intended to limit the present invention. A person with ordinary knowledge in the technical field to which the present invention belongs may make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the protection scope of the present invention shall be determined by the definition of the claims.
Claims
1. A method for preparing a fluorescent donor capable of controlling the release of hydrogen sulfide and carbon monoxide, comprising the following steps: S1. Dissolve the natural product flavonol (COD) in 15 mL of dry tetrahydrofuran to obtain a dichloromethane mixed solution 1 containing COD; S2. The mixed solution 1 described in step S1 was vigorously stirred at 0°C, and 15 mL of a dichloromethane mixed solution containing thiophosgene was slowly added, and the mixture was stirred and reacted for 1 h in an ice bath; after the temperature of the mixed solution returned to room temperature, the mixture was stirred and reacted for 2 h to obtain a mixed solution 2; S3. The mixed solution 2 described in step S2 is placed back in an ice bath at 0°C, a phenyl Grignard reagent is added to react, and after the reaction solution temperature gradually returns to room temperature, the end point of the reaction is monitored by TLC; S4. After the reaction is completed in step S3, an excess of saturated ammonium chloride solution is added to quench the Grignard reagent, and the reaction solution is extracted three times with dichloromethane, and the organic phases are combined and dried to obtain a solid mixture; S5. Separate and purify the solid mixture obtained in step S4 by column chromatography to finally obtain a yellow fluorescent donor.
2. The method for preparing a fluorescent donor capable of controlling the release of hydrogen sulfide and carbon monoxide according to claim 1, characterized in that: The amount of the natural product flavonol (COD) added in step S1 is 300 mg.
3. The method for preparing a fluorescent donor capable of controlling the release of hydrogen sulfide and carbon monoxide according to claim 1, characterized in that: The amount of thiophosgene added to the dichloromethane mixed solution containing thiophosgene in step S2 is 180 mg.
4. The method for preparing a fluorescent donor capable of controlling the release of hydrogen sulfide and carbon monoxide according to claim 1, characterized in that: The phenyl Grignard reagent described in step S3 is one of 3-methoxyphenylmagnesium bromide, 3,4-(methylenedioxy)phenylmagnesium bromide, and 4-fluorophenylmagnesium bromide.
5. The method for preparing a fluorescent donor capable of controlling the release of hydrogen sulfide and carbon monoxide according to claim 1, characterized in that: The amount of the phenyl Grignard reagent added in step S3 is 3 to 5 times equivalent.
6. The method for preparing a fluorescent donor capable of controlling the release of hydrogen sulfide and carbon monoxide according to claim 1, characterized in that: The method for monitoring the end point of the reaction by TLC described in step S3 is to take an appropriate amount of reaction solution, add water to quench the reaction, take the mixed solution and spot it on the TLC plate, blow dry the solvent with a hair dryer, use a mixed solution of dichloromethane and methanol as the developing agent, and develop it with a dichloromethane:methanol ratio of 20:
1. It is observed that the COD point disappears and the new points appearing in the reaction are no longer increasing.
7. The method for preparing a fluorescent donor capable of controlling the release of hydrogen sulfide and carbon monoxide according to claim 1, characterized in that: The column chromatography method described in step S4 is used for separation and purification under the conditions of using 400 mesh silica gel, a separation phase of a mixture of dichloromethane and methanol, dichloromethane:methanol=30:1, and pressure passing through the column.
8. A fluorescent donor capable of controlling the release of hydrogen sulfide and carbon monoxide prepared by the method according to claims 1 to 7, characterized in that: The donor can controllably release two gas signal molecules and give fluorescence signal changes, which can be used to monitor gas release in real time: in the presence of cysteine, hydrogen sulfide is released and red enhanced fluorescence is produced; Then, under blue light irradiation, carbon monoxide is released and the red fluorescence signal gradually weakens.
9. Use of the fluorescent donor capable of controllably releasing hydrogen sulfide and carbon monoxide as claimed in claim 8 in biological sample detection.
